Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Zoetis EBITDA 2011-2024 | ZTS

Zoetis annual and quarterly EBITDA history from 2011 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Zoetis EBITDA for the quarter ending March 31, 2024 was $0.931B, a 5.8% increase year-over-year.
  • Zoetis EBITDA for the twelve months ending March 31, 2024 was $3.717B, a 11.69% increase year-over-year.
  • Zoetis 2023 annual EBITDA was $3.666B, a 9.69% increase from 2022.
  • Zoetis 2022 annual EBITDA was $3.342B, a 5.76% increase from 2021.
  • Zoetis 2021 annual EBITDA was $3.16B, a 18.44% increase from 2020.
  
Zoetis Annual EBITDA
(Millions of US $)
2023 $3,666
2022 $3,342
2021 $3,160
2020 $2,668
2019 $2,436
2018 $2,204
2017 $1,942
2016 $1,634
2015 $868
2014 $1,141
2013 $1,012
2012 $941
2011 $635
2010 $363
Zoetis Quarterly EBITDA
(Millions of US $)
2024-03-31 $931
2023-12-31 $835
2023-09-30 $900
2023-06-30 $1,051
2023-03-31 $880
2022-12-31 $773
2022-09-30 $835
2022-06-30 $840
2022-03-31 $894
2021-12-31 $677
2021-09-30 $825
2021-06-30 $805
2021-03-31 $853
2020-12-31 $587
2020-09-30 $770
2020-06-30 $651
2020-03-31 $660
2019-12-31 $602
2019-09-30 $691
2019-06-30 $608
2019-03-31 $535
2018-12-31 $578
2018-09-30 $556
2018-06-30 $546
2018-03-31 $524
2017-12-31 $543
2017-09-30 $514
2017-06-30 $445
2017-03-31 $440
2016-12-31 $335
2016-09-30 $434
2016-06-30 $433
2016-03-31 $432
2015-12-31 $162
2015-09-30 $348
2015-06-30 $52
2015-03-31 $306
2014-12-31 $238
2014-09-30 $317
2014-06-30 $280
2014-03-31 $306
2013-12-31 $214
2013-09-30 $263
2013-06-30 $270
2013-03-31 $265
2012-12-31 $134
2012-09-30 $274
2012-06-30 $314
2012-03-31 $227
2011-12-31
2010-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $80.518B $8.544B
Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified business, which caters to eight core species ' cattle, swine, poultry, fish and sheep (collectively, livestock) and dogs, cats and horses (collectively, companion animals). It directly markets its products to veterinarians and livestock producers. The outstanding growth rate in the companion animal medicines, vaccines and diagnostics sector is being driven by economic development, related increases in disposable income and a rise in pet ownership and spending on pet care.Zoetis has been working on strengthening its product portfolio through acquisitions and deals.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $59.516B 26.60
Takeda Pharmaceutical (TAK) Japan $40.858B 8.28
Merck (MKGAF) Germany $21.654B 21.00
Astellas Pharma (ALPMY) Japan $17.952B 28.34
Sandoz Group AG (SDZNY) Switzerland $15.762B 0.00
United Therapeutics (UTHR) United States $14.058B 14.98
Neurocrine Biosciences (NBIX) United States $13.517B 37.00
Shionogi (SGIOY) Japan $11.482B 9.98
Catalent (CTLT) United States $10.209B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.379B 0.00
Ionis Pharmaceuticals (IONS) United States $6.894B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.754B 7.42
Revolution Medicines (RVMD) United States $6.357B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.088B 0.00
Orion OYJ (ORINY) Finland $6.014B 25.36
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.561B 0.00
Summit Therapeutics (SMMT) United States $5.525B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.428B 0.00
Corcept Therapeutics (CORT) United States $3.338B 30.25
Arrowhead Pharmaceuticals (ARWR) United States $3.191B 0.00
Dyne Therapeutics (DYN) United States $3.095B 0.00
PTC Therapeutics (PTCT) United States $2.658B 0.00
Indivior (INDV) United States $2.258B 10.71
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.982B 11.26
Recursion Pharmaceuticals (RXRX) United States $1.800B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.776B 17.29
NewAmsterdam Pharma (NAMS) Netherlands $1.758B 0.00
Evotec AG (EVO) Germany $1.619B 0.00
Ardelyx (ARDX) United States $1.513B 0.00
Soleno Therapeutics (SLNO) United States $1.395B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.375B 0.00
Pacira BioSciences (PCRX) United States $1.299B 12.35
BioCryst Pharmaceuticals (BCRX) United States $1.261B 0.00
Xencor (XNCR) United States $1.184B 0.00
Calliditas Therapeutics AB (CALT) Sweden $1.148B 0.00
Enliven Therapeutics (ELVN) United States $1.103B 0.00
4D Molecular Therapeutics (FDMT) United States $1.082B 0.00
Collegium Pharmaceutical (COLL) United States $1.061B 6.35
Ocular Therapeutix (OCUL) United States $1.047B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.970B 15.12
Cassava Sciences (SAVA) United States $0.909B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.902B 0.00
Cronos Group (CRON) Canada $0.895B 0.00
USANA Health Sciences (USNA) United States $0.867B 14.18
Relay Therapeutics (RLAY) United States $0.836B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.802B 0.00
ARS Pharmaceuticals (SPRY) United States $0.780B 0.00
Harrow (HROW) United States $0.743B 0.00
Sage Therapeutics (SAGE) United States $0.643B 0.00
Exscientia (EXAI) United Kingdom $0.631B 0.00
Silence Therapeutics (SLN) United Kingdom $0.569B 0.00
ProKidney (PROK) United States $0.555B 0.00
Savara (SVRA) United States $0.527B 0.00
Siga Technologies (SIGA) United States $0.523B 6.69
Heron Therapeutics (HRTX) United States $0.514B 0.00
KalVista Pharmaceuticals (KALV) United States $0.508B 0.00
Lexeo Therapeutics (LXEO) United States $0.490B 0.00
Larimar Therapeutics (LRMR) United States $0.469B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.469B 0.00
Bioventus (BVS) United States $0.453B 17.33
Altimmune (ALT) United States $0.453B 0.00
OmniAb (OABI) United States $0.443B 0.00
Esperion Therapeutics (ESPR) United States $0.438B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.405B 0.00
Verve Therapeutics (VERV) United States $0.400B 0.00
Lyell Immunopharma (LYEL) United States $0.352B 0.00
Organogenesis (ORGO) United States $0.350B 66.00
Tourmaline Bio (TRML) United States $0.339B 0.00
Xeris Biopharma Holdings (XERS) United States $0.335B 0.00
Korro Bio (KRRO) United States $0.310B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.306B 0.00
Nature's Sunshine Products (NATR) United States $0.282B 17.89
Enanta Pharmaceuticals (ENTA) United States $0.268B 0.00
Black Diamond Therapeutics (BDTX) United States $0.264B 0.00
Nanobiotix S.A (NBTX) France $0.264B 0.00
Foghorn Therapeutics (FHTX) United States $0.244B 0.00
Aquestive Therapeutics (AQST) United States $0.236B 0.00
ESSA Pharma (EPIX) Canada $0.230B 0.00
Eliem Therapeutics (ELYM) United States $0.224B 0.00
Profound Medical (PROF) Canada $0.217B 0.00
Century Therapeutics (IPSC) United States $0.214B 0.00
Elite Pharmaceuticals (ELTP) United States $0.214B 20.00
Fractyl Health (GUTS) United States $0.212B 0.00
Nektar Therapeutics (NKTR) United States $0.210B 0.00
Akebia Therapeutics (AKBA) United States $0.207B 0.00
Avita Medical (RCEL) United States $0.205B 0.00
Prelude Therapeutics (PRLD) United States $0.203B 0.00
Aldeyra Therapeutics (ALDX) United States $0.202B 0.00
Zevra Therapeutics (ZVRA) United States $0.201B 0.00
Innate Pharma SA (IPHYF) France $0.200B 0.00
Pyxis Oncology (PYXS) United States $0.189B 0.00
Acrivon Therapeutics (ACRV) United States $0.178B 0.00
Incannex Healthcare (IXHL) Australia $0.169B 0.00
Adherex Technologies (FENC) United States $0.168B 205.00
Rigel Pharmaceuticals (RIGL) United States $0.167B 0.00
Achieve Life Sciences (ACHV) Canada $0.159B 0.00
Context Therapeutics (CNTX) United States $0.151B 0.00
CytoDyn (CYDY) United States $0.148B 0.00
Metagenomi (MGX) United States $0.141B 0.00
MediWound (MDWD) Israel $0.138B 0.00
Cardiol Therapeutics (CRDL) Canada $0.138B 0.00
Galectin Therapeutics (GALT) United States $0.137B 0.00
Regulus Therapeutics (RGLS) United States $0.133B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.131B 8.77
Telomir Pharmaceuticals (TELO) United States $0.127B 0.00
Assertio Holdings (ASRT) United States $0.125B 5.70
OptiNose (OPTN) United States $0.122B 0.00
Karyopharm Therapeutics (KPTI) United States $0.121B 0.00
VAXART, INC (VXRT) United States $0.118B 0.00
Citius Pharmaceuticals (CTXR) United States $0.115B 0.00
Journey Medical (DERM) United States $0.103B 0.00
FibroGen (FGEN) United States $0.102B 0.00
Relmada Therapeutics (RLMD) United States $0.090B 0.00
AlloVir (ALVR) United States $0.090B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
PMV Pharmaceuticals (PMVP) United States $0.085B 0.00
ProPhase Labs (PRPH) United States $0.081B 0.00
Aclaris Therapeutics (ACRS) United States $0.079B 0.00
Arch Biopartners (ACHFF) Canada $0.078B 0.00
SCYNEXIS (SCYX) United States $0.077B 1.08
Conduit Pharmaceuticals (CDT) United States $0.075B 0.00
Vivani Medical (VANI) United States $0.070B 0.00
Champions Oncology (CSBR) United States $0.069B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.068B 0.00
CASI Pharmaceuticals (CASI) China $0.066B 0.00
Nutriband (NTRB) United States $0.059B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.054B 0.00
Carisma Therapeutics (CARM) United States $0.053B 0.00
Mural Oncology (MURA) Ireland $0.052B 0.00
Tempest Therapeutics (TPST) United States $0.048B 0.00
BioLineRx (BLRX) Israel $0.046B 0.00
Inotiv (NOTV) United States $0.045B 0.00
Protara Therapeutics (TARA) United States $0.045B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.043B 0.00
DURECT (DRRX) United States $0.042B 0.00
Lipocine (LPCN) United States $0.041B 0.00
ElectroCore (ECOR) United States $0.039B 0.00
Natural Alternatives (NAII) United States $0.038B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.036B 0.00
Rafael Holdings (RFL) United States $0.035B 0.00
Surrozen (SRZN) United States $0.032B 0.00
Enlivex Therapeutics (ENLV) Israel $0.031B 0.00
VYNE Therapeutics (VYNE) United States $0.029B 0.00
NRx Pharmaceuticals (NRXP) United States $0.028B 0.00
BioVie (BIVI) United States $0.027B 0.00
Aptorum Group (APM) United Kingdom $0.024B 0.00
Oncternal Therapeutics (ONCT) United States $0.023B 0.00
Viracta Therapeutics (VIRX) United States $0.023B 0.00
Gain Therapeutics (GANX) United States $0.023B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.022B 0.00
Minerva Neurosciences (NERV) United States $0.021B 0.00
GlycoMimetics (GLYC) United States $0.020B 0.00
PolyPid (PYPD) Israel $0.020B 0.00
TherapeuticsMD (TXMD) United States $0.020B 0.00
Iterum Therapeutics (ITRM) Ireland $0.020B 0.00
JanOne (JAN) United States $0.020B 0.00
MEI Pharma (MEIP) United States $0.020B 0.75
Indaptus Therapeutics (INDP) United States $0.019B 0.00
SHINECO (SISI) China $0.019B 0.00
Jaguar Animal Health (JAGX) United States $0.018B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Lyra Therapeutics (LYRA) United States $0.016B 0.00
Talphera (TLPH) United States $0.015B 0.00
Unicycive Therapeutics (UNCY) United States $0.015B 0.00
Avalo Therapeutics (AVTX) United States $0.014B 0.00
Mannatech (MTEX) United States $0.013B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.012B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.012B 0.00
Alaunos Therapeutics (TCRT) United States $0.012B 0.00
Cosmos Health (COSM) Greece $0.012B 0.00
Traws Pharma (TRAW) United States $0.011B 0.00
Dominari Holdings (DOMH) United States $0.011B 0.00
Redhill Biopharma (RDHL) Israel $0.011B 0.00
Inhibikase Therapeutics (IKT) United States $0.010B 0.00
Universe Pharmaceuticals INC (UPC) China $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Plus Therapeutics (PSTV) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Molecular Templates (MTEM) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.006B 0.00
Heatwurx (PCSA) United States $0.006B 0.00
Ainos (AIMD) United States $0.006B 0.00
CERo Therapeutics Holdings (CERO) United States $0.005B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.004B 0.00
Bio-Path Holdings (BPTH) United States $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.001B 0.00
Qualigen Therapeutics (QLGN) United States $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 4.83
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 31.75